This is how it goes with biotechs. It's a slow grind. Takes a long time.

Most companies provide the minimum required updates. CYDY provides too many updates. Particularly on things that are possible

Mexico is a perfect example. Any other biotech may have tried to start a trial and it didn't happen for one reason or another. The difference? We would have never known about it.

Sometimes the extra communication is good, sometimes not.